Movement disorders and mitochondrial dysfunction

Current Opinion in Neurology

Volumn 10, Issue 4, 1997, Pages 351-356

  Hanna, Michael G ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

BRAIN MITOCHONDRION; CHOREA; DYSTONIA; HUMAN; HUNTINGTON CHOREA; LEIGH DISEASE; MOTOR DYSFUNCTION; MYOCLONUS; PARKINSON DISEASE; PARKINSONISM; RESPIRATORY CHAIN; SHORT SURVEY;

EID: 0030846427     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199708000-00012     Document Type: Short Survey

References (56)

1. Morgan-Hughes JA: Mitochondrial diseases. In Myology, 2nd edn. Edited by Engel AG, Franzini-Armstrong C. McGraw-Hill, New York: 1994: 1610-1660.
2. Shoffner JM Wallace DC: Oxidative phosphorylation diseases. In The Metabolic Basis of Inherited Disease. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill information services company; 1995:1535-1610.
3. Schapira AHV: Mitochondrial function in Huntington's disease: clues for pathogenesis and prospects for treatment. Ann Neurol 1997, 41:141-142.
4. Shoffner JM: Mitochondrial defects in basal ganglia diseases. Curr Opin Neurol 1995, 8:474-479.
5. Benecke R, Strunper P, Weiss H: Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 1992, 9:642-649.
6. Reichmann H, Naumann M, Hauck S, Janetzky B: Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalised dystonia. Movement Disord 1994, 9:597-600.
7. Warner TT, Marinho C, Cleeter M, Cooper JM, Schapira AHV: Complex I activity in chromosome 9 linked (DYT1) and non-linked idiopathic torsion dystonia [Abstract P795]. Movement Disord 1996, 11:211.
8. Lera G, Bhatia K, Marsden CD: Dystonia as the major manifestation of Leigh's syndrome. Movement Disord 1994, 9:642-649.
9. Macaya A, Munell F, Burke RE, DeVivo DC: Disorders of movement in Leigh syndrome. Neuropaediatrics 1993, 24:60-67.
10. Rahman S, Blok RB, Dahl HHM, Danks DM, Kirdy DM, Chow CW, Chrisodoulou J, Thorburn DR: Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996, 39:343-351. A detailed analysis of 67 Australian patients with definite or probable LS is provided. Biochemical or DNA defects were detected in 80% of the definite group. Twenty-nine patients had enzyme defects, complex I being the commonest. Only 11 patients had mtDNA point mutations. Twenty patients were noted to have involutary movements and 13 had dystonia. The movement disorders did not associate with any particular biochemical or genetic defect.
11. •] in 66 British patients with LS. Complex I deficiency was confirmed to be more common than previously noted, being second only to complex IV deficiency. MtDNA mutations were once again infrequent, being found in only two patients. Full clinical details on the seven patients with complex I deficiency were given and four had dystonia. It was stated that 50% of patients with complex I or IV defects had 'extrapyramidal signs'.
12. Sweeney MG, Hammans SR, Duchen LW, Cooper JM, Schapira AHV, Kennedy CR, Jacobs JM, Youl BD, Morgan-Hughes JA, Harding AE: Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy. J Neurol Sci 1994, 121:57-65.
13. Huang WY, Chi CS, Nak SC, Wu HM, Tang MT: Leigh syndrome presenting with dystonia: report of one case. Acta Paediatr Sin 1995, 36:378-381.
14. De Meirleir L, Seneca S, Lissens W, Schoentjes E, Desprechins B: Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Paediatr Neurol 1995, 13:242-246.
15. Thyagarajan D, Shanske S, Vazquez-Memije M, DeVivi D, DiMauro S: A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995, 38:468-472.
16. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 1995, 11:144-148.
17. Novotny EJ Jr, Singh G, Wallace DC, Dorfman LJ, Louis A, Sogg RL, Steinman L: Leber's disease and dystonia: a mitochondrial disease. Neurology 1986, 29:364-369.
18. Howell N, Kubacka I, Xu M, McCullogh DA: Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet 1991, 48:935-942.
19. Larsson NG, Anderson O, Holme E, Oldfors A, Wahlstrum J: Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 1991, 30:701-708.
20. Jun AS, Brown MD, Wallace DC: A mitochondrial DNA mutation at nucleotide position 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A 1994, 91:6206-6210.
21. Shoffner JM, Brown MD, Stugard C, Jun AS, Pollock S, Haas RH, Kaufman A, Koontz D, Kim Y, Graham JR et al.: Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995, 38:163-169.
22. Jun AS, Trounce IA, Brown MD, Shoffner JM, Wallace DC: Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber's hereditary optic neuropathy and dystonia. Mol Cell Biol 1996, 16:771-777. Using transmitochondrial cybrids direct evidence is provided that the 14459 mutation induces a decrease in complex I activity. This would suggest that the complex I defect is the cause of the dystonia in these cases.
23. Bruyn GW, Bots GTAM, Went LN, Klinkhammer PJJM: Heriditary spastic dystonia with Leber's heriditary optic neuropathy: neuropathological findings. J Neuro Sci 1992, 118:55-61.
24. DeVries DD, Went LN, Bruyn GW, Scholte HR, Hofstra RMW, Bolhuis PA, van Oost BA: Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996, 58:703-711.
25. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AHV, Marsden CD: Brain skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992, 115:333-342.
26. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD: Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990, 54:823-827.
27. Martin MA, Molina JA, Jimenez-Jimenez FJ, Benito-Leon J, Orti-Parjera M, Campos Y, Arenas J and the Grupo Centro de Trastornos del Movimento: Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Neurology 1996, 46:1343-1346.
28. Schapira AHV: Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Movement Disord 1994, 9:125-138.
29. Schulz JB, Beal MF: Mitochondrial dysfunction in movement disorders. Curr Opin Neurol 1994, 7:333-339.
30. Wood NW: Genes and parkinsonism. J Neurol Neurosurg Psychiatry 1997, 4:305-309. A detailed appraisal of the possible involvement of nuclear and mitochondrial genetic factors in the aetiology of PD and other akinetic rigid syndromes is provided.
31. Shoffner J, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R: Mitochondrial DNA mutations associated with Alzheimer's and Parkinson's disease. Genomics 1993, 17:171-184.
32. Kosel S, Lucking CB, Egensberger R, Mehraein P, Graebe MB: Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 1996, 44:174-183.
33. Bandmann O, Sweeney MG, Daniel SE, Marsden CD, Wood NW: Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. J Neurol (in press).
34. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JS, Bennett JP, Davis RE, Parker WD: Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996, 40:663-671. Using a transmitochondrial cybrid system donor mitochondria from patients with PD were shown to result in a stable 20% decrease in complex I activity compared with control individuals. This is direct evidence that mutations in mtDNA are the likely cause of this complex I defect. The next step is to sequence the entire mtDNA in these patients.
35. Truong DD, Harding AE, Scaravilli F, Smith SJ, Morgan-Hughes JA, Marsden CD: Movement disorders in mitochondrial myopathies: a study of nine cases with two autopsy studies. Movement Disord 1990, 5:109-117.
36. Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnball DM, Bindoff LA: Presentation and clinical investigation of mitochondrial respiratory chain disease: a study of 51 patients. Brain 1995, 118:339-357.
37. (3243) mutation: a clinical and genetic study. Brain 1995, 118:721-734.
38. Holt IJ, Harding AE, Cooper JM, Schapira AHV, Toscano A, Clark JB, Morgan-Hughes JA: Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989, 26:699-708.
39. Hirano M, DiMauro S: Clinical features of mitochondrial myopathies and encephalopathies. In Handbook of Muscle Disease. Edited by Lane RJM. New York: Marcel Dekker Inc.; 1996:479-504.
40. Checcarelli N, Prelle A, Moggio M, Comi G, Bresolin N, Papadimitriou A, Fagiolari G, Bordoni A, Scarlato G: Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalopathy. J Neurol Sci 1994, 123:74-79.
41. Chalmers RM, Brockington M, Howard RS, Lecky BRF, Morgan-Hughes JA, Harding AE: Mitochondrial encephalopathy with multiple mitochondrial deletions: a report of two families and two sporadic cases with unusual clinical and neuropathological features. J Neurol Sci 1996, 143:41-45.
42. Lys(8344) (MERRF) mutation. J Neurol 1994, 241:351-340.
43. (8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF): relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993, 116:617-632.
44. Shoffner JM, Lott MT, Lezza AMS, Siebel P, Ballinger SW, Wallace DC: Myoclonic epilepsy and ragged red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA Lys mutation. Cell 1990, 61:931-937.
45. Leu(UUR) may cause an MERRF syndrome. J Neurol Neurosurg Psychiatry 1996, 61:47-51.
46. Verma A, Moraes CT, Shebert RT, Bradley WG: A MERRFiPEO overlap syndrome associated with the mitochondrial DNA 3243 mutation. Neurology 1996, 46:1334-1336.
47. Silvestri G, Moraes CT, Shanske S: A new mtDNA mutation in the tRNA Lys gene associated with myoclonic epilepsy and ragged red fibres (MERRF). Am J Hum Genet 1992, 51:1213-1217.
48. Traff J, Holme E, Ekbom K, Nilsson BY: Ekbom's syndrome of photomyoclonus, cerebellar ataxia and cervical lipoma is associated with the tRNA (Lys). Acta Neurol Scand 1995, 92:394-397.
49. Ser(UCN) gene. Hum Mol Genet 1995, 4:1421-1427.
50. Van Domburg PHMF, Gabreels-Feston AAWM, Gabreels FJM, de Coo R, Ruitenbeek W, Wessling P, ter Laak H: Mitochondrial cytopathy presenting as hereditary neuropathy with progressive external ophthalmoplegia, ataxia and fatal myoclonic epileptic status. Brain 1996, 119:997-1010.
51. Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE: A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological and molecular genetic study. Ann Neurol 1995, 37:400-403.
52. Brennan WA, Bird ED, Aprille JR: Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985, 44:1948-1950.
53. Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF: Chronic mitochondrial energy impairmant produces selective striatal degeneration and abnormal chorieform movements in primates. Proc Natl Acad Sci U S A 1995, 92:7105-7109.
54. Zeevalk GD, Derr-Yellin E, Nicklas WJ: NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J Neurochem 1995, 64:455-456.
55. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AHV: Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996, 39:385-389.
56. 10. Ann Neuron 1997, 41:160-165.